|
C9ORF64 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.697800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.820000E-02 |
| Normal-vs-Stage2 |
2.408600E-01 |
| Normal-vs-Stage3 |
1.815590E-01 |
| Normal-vs-Stage4 |
1.849550E-01 |
| Stage1-vs-Stage2 |
9.991400E-01 |
| Stage1-vs-Stage3 |
7.793800E-01 |
| Stage1-vs-Stage4 |
4.222600E-01 |
| Stage2-vs-Stage3 |
8.224200E-01 |
| Stage2-vs-Stage4 |
4.279200E-01 |
| Stage3-vs-Stage4 |
5.805000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002780E-01 |
| Normal-vs-AfricanAmerican |
8.642000E-02 |
| Normal-vs-Asian |
1.847780E-01 |
| Caucasian-vs-AfricanAmerican |
6.260000E-01 |
| Caucasian-vs-Asian |
1.699750E-01 |
| AfricanAmerican-vs-Asian |
2.055000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.180440E-01 |
| Normal-vs-Female |
7.818200E-02 |
| Male-vs-Female |
5.299200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.978000E-02 |
| Normal-vs-Extreme_Weight |
1.657900E-02 |
| Normal-vs-Obese |
4.731000E-01 |
| Normal-vs-Extreme_Obese |
6.932200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.128000E-01 |
| Normal_Weight-vs-Obese |
3.217400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.794400E-01 |
| Extreme_Weight-vs-Obese |
3.160000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.025000E-01 |
| Obese-vs-Extreme_Obese |
9.560400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.411920E-02 |
| Normal-vs-Age(41-60Yrs) |
7.335600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.388000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.092600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.641550E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.271010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.462200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.121200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.156000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.084400E-01 |
| Normal-VS-Type2 PRCC |
2.313000E-01 |
| Normal-VS-KIRP CIMP |
9.62930000000251E-05 |
| Normal-VS-Unclassified PRCC |
6.995600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.834600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.80510000000034E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.108800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.296100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.668600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.984900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.010500E-02 |
| Normal-vs-N1 |
1.769430E-01 |
| Normal-vs-N2 |
6.24699999999256E-05 |
| N0-vs-N1 |
7.527400E-01 |
| N0-vs-N2 |
1.044220E-01 |
| N1-vs-N2 |
2.860600E-01 |
|
|
